Live Breaking News & Updates on Philippe Bousso

Stay updated with breaking news from Philippe bousso. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CAR T cell therapy: study shows remote destruction of tumor cells

The aim of immunotherapy strategies is to use cells in the patient s own immune system to destroy tumor cells. CAR T cell therapy is an immunotherapy that is effective in treating blood cancer. Around 35,000 people are affected by blood cancer each year in France, with 1.24 million cases worldwide. ....

France General , Philippe Bousso , Institut Pasteur , Paris Public Hospital Network , European Research Council , French National Cancer Institute Inca , Immune Responses Unit , French National Cancer Institute , European Research ,

Study raises new hopes for blood cancer patients with an incomplete response to CAR T cell therapy

The aim of immunotherapy strategies is to use cells in the patient's own immune system to destroy tumor cells. CAR T cell therapy is an immunotherapy that is effective in treating blood cancer. ....

France General , Megan Craig , Philippe Bousso , Institut Pasteur , Paris Public Hospital Network , Immune Responses Unit ,

Immunotherapy for blood cancer: Remote destru

The aim of immunotherapy strategies is to use cells in the patient's own immune system to destroy tumor cells. CAR T cell therapy is an immunotherapy that is effective in treating blood cancer. Around 35,000 people are affected by blood cancer each year in France, with 1.24 million cases worldwide. By closely investigating some of the immune cells generated during this therapy, known as CD4 T cells, scientists from the Institut Pasteur and Inserm, in collaboration with clinicians from the Paris Public Hospital Network (AP-HP), discovered that these cells are capable of remotely neutralizing tumor cells by producing interferon gamma (IFN-γ). This study raises new hopes for blood cancer patients with an incomplete response to CAR T cell therapy and for cancers sensitive to IFN-γ. The results were published on May 29, 2023 in the journal Nature Cancer. ....

France General , Institut Pasteur , Philippe Bousso , European Research Council , French National Cancer Institute Inca , Method Of Research , Paris Public Hospital Network , Immune Responses Unit , French National Cancer Institute , European Research ,